Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
PRESIDENT AND CEO, Director, 10%+ Owner
-
Stock Symbol
-
SPRY on Nasdaq
Richard E. Lowenthal - trading volume in the past year for ARS Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
4.32M |
$49.6M |
$11.50 |
Sep 10, 2024 |
Direct |
|
|
Common Stock |
3.41M |
$39.2M |
$11.50 |
Sep 10, 2024 |
By Spouse |
|
|
Common Stock |
1.5M |
$17.2M |
$11.50 |
Sep 10, 2024 |
By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020 |
|
|
Common Stock |
1.45M |
$16.7M |
$11.50 |
Sep 10, 2024 |
By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006 |
|
|
Common Stock |
1.4M |
$16.1M |
$11.50 |
Sep 10, 2024 |
By Richard Lowenthal Charitable Remainder UniTrust Dated January 7, 2020 |
|
|
Stock Option (right to buy) |
34.5K |
|
|
Apr 23, 2024 |
By Spouse |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.